Formats: Text / Copyright: Public domain - Digital Collections - National Library of Medicine Search Results

Start Over Formats Text ✖ Copyright Public domain ✖

48261. COVID-19: HHS funds allocated to support disproportionately affected communities : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, January 2023
Subject(s):: COVID-19 -- economics
Disaster Planning -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Pandemics -- economics
Arizona
Louisiana
Michigan
New Hampshire
Washington
United States. Department of Health and Human Services

48262. Medicare Advantage: Plans generally offered some supplemental benefits, but CMS has limited data on utilization : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, January 2023
Subject(s):: Government Regulation
Insurance, Medigap -- legislation & jurisprudence
Legislation, Medical
Medicare Part C -- statistics & numerical data
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

48263. Nursing homes: CMS should make ownership information more transparent for consumers : report to the Honorable Richard Neal, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, January 2023
Subject(s):: Government Regulation
Information Dissemination
Nursing Homes -- economics
Nursing Homes -- organization & administration
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

48264. Institutional review boards: Actions needed to improve federal oversight and examine effectiveness : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, January 2023
Subject(s):: Ethics Committees, Research -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Research Subjects -- legislation & jurisprudence
Risk Assessment -- legislation & jurisprudence
United States

48265. Tracking the funds: specific fiscal year 2022 provisions for Department of Health and Human Services : report to congressional committees

Publication:: [Washington, DC] : United States Government Accountability Office, October 2022
Subject(s):: Financing, Government -- organization & administration
Financing, Government -- standards
Government Regulation
Legislation, Medical
United States
United States. Department of Health and Human Services

48266. Access to preventive services without cost-sharing: evidence from the Affordable Care Act

Publication:: Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, January 11, 2022
Subject(s):: Cost Sharing
Health Services Accessibility
Preventive Health Services -- economics
Facilities and Services Utilization -- statistics & numerical data
United States
United States.

48267. Routine vaccinations: adult rates vary by vaccine type and other factors : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, September 2022
Subject(s):: Adult
Government Regulation
Health Expenditures -- statistics & numerical data
Healthcare Disparities -- statistics & numerical data
Legislation, Medical
Vaccination Coverage -- statistics & numerical data
COVID-19
United States

48268. Public health preparedness: HHS should address strategic national stockpile requirements and inventory risks : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, October 2022
Subject(s):: Civil Defense -- statistics & numerical data
Government Regulation
Legislation, Medical
Strategic Stockpile -- organization & administration
United States
United States. Department of Health and Human Services

48269. Federal economic stimulus projected to cut poverty in 2021, though poverty may rise as benefits expire

Author(s):: Macartney, Suzanne E., author
Ghertner, Robin, author
Wheaton, Laura, author
Giannarelli, Linda, author
Publication:: Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, February 2022
Subject(s):: COVID-19 -- economics
Poverty -- ethnology
Poverty -- legislation & jurisprudence
Poverty -- statistics & numerical data
Public Assistance -- statistics & numerical data
Income Tax
United States
United States.

48270. Best practices for convening a GRAS panel: guidance for industry

Publication:: College Park, MD : Center for Food Safety and Applied Nutrition, December 2022
Subject(s):: Advisory Committees
Consumer Product Safety
Government Regulation
Legislation, Drug
United States
United States. Food and Drug Administration

48271. Failure to respond to an ANDA complete response letter within the regulatory timeframe: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, December 2022
Subject(s):: Drug Approval
Drugs, Generic
Government Regulation
United States
United States. Food and Drug Administration

48272. Enhancing data infrastructure to improve women’s health outcomes

Publication:: Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, October 2022
Subject(s):: Data Collection
Outcome Assessment, Health Care
Registries
Women's Health
United States

48273. Recommendations to reduce the risk of transfusion-transmitted malaria: guidance for industry

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, December 2022
Subject(s):: Blood Banking -- methods
Blood-Borne Infections -- prevention & control
Government Regulation
Malaria -- prevention & control
Malaria -- transmission
United States
United States. Food and Drug Administration

48274. Homeopathic drug products: guidance for FDA staff and industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, December 2022
Subject(s):: Government Regulation
Homeopathy -- legislation & jurisprudence
Materia Medica
United States
United States. Food and Drug Administration

48275. Pharmacokinetic-based criteria for supporting alternative dosing regimens of programmed cell death receptor-1 (PD-1) or programmed cell death-ligand 1 (PD-L1) blocking antibodies for treatment of patients with cancer: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, December 2022
Subject(s):: Government Regulation
Immune Checkpoint Inhibitors -- administration & dosage
Immune Checkpoint Inhibitors -- pharmacokinetics
Programmed Cell Death 1 Receptor -- administration & dosage
United States
United States. Food and Drug Administration

48276. E19: a selective approach to safety data collection in specific late-stage preapproval or post-approval clinical trials : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, December 2022
Subject(s):: Clinical Trials as Topic
Data Collection
Government Regulation
Patient Safety
United States
United States. Food and Drug Administration

48277. Compounding certain beta-lactam products in shortage under Section 503A of the Federal Food, Drug, and Cosmetic Act: immediately in effect guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, November 2022
Subject(s):: Anti-Bacterial Agents
beta-Lactams
Drug Compounding
Government Regulation
Legislation, Drug
United States
United States. Food and Drug Administration

48278. Referencing the definition of “device” in the Federal Food, Drug, and Cosmetic Act in guidance, regulatory documents, communications, and other public documents: guidance for industry and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, November 14, 2022
Subject(s):: Government Regulation
Medical Device Legislation
Terminology as Topic
United States
United States. Food and Drug Administration
United States.

48279. Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial: guidance for industry

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, November 2022
Subject(s):: Cell- and Tissue-Based Therapy
Clinical Trials as Topic
Genetic Therapy
Government Regulation
United States
United States. Food and Drug Administration

48280. How increased funding can advance the mission of the Indian Health Service to improve health outcomes for American Indians and Alaska Natives

Publication:: Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, July 2022
Subject(s):: American Indian or Alaska Native -- statistics & numerical data
Financing, Government
Health Status Disparities
Healthcare Disparities
Outcome Assessment, Health Care
United States
United States. Indian Health Service.